CJC-1295 + Ipamorelin 5 mg + 5 mgPakke med 10 hetteglass6 på lagerSpar 22 %
Utvalgtpeptideintermediate6 på lager

CJC-1295 + Ipamorelin 5 mg + 5 mg

Klassisk GHRH + ghrelinmimetisk stack

CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.

Dose
5mg + 5mg / hetteglass
Form
Lyofilisert pulver
Pakke
Pakke med 10 hetteglass

Kun til forskningsbruk. Denne forbindelsen selges strengt til in vitro-forskning og laboratorieformål og er ikke beregnet for menneskelig konsum eller terapeutisk bruk. Ved kjøp bekrefter du at du er en kvalifisert forsker og godtar vår fullstendige ansvarsfraskrivelse.

2 000 kr NOK
Spar 22 %
Pakke med 10 hetteglass
Før 2 566 kr NOK
Selges som pakke med 10 hetteglass

Bare 6 pakker igjen

🧪Labverifisert
✓Testet av tredjepart
⚡Rask frakt over hele verden
🔒Sikker kortbetaling
Oversikt

Kombinert forskningshetteglass som parrer GHRH-analogen CJC-1295 med den selektive ghrelinmimetikken Ipamorelin. Den mest studerte dobbelmekanisme-GH-sekretagogstacken i peptidforskning.

CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.

Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.

Mekanisme

CJC-1295 støtter basal GHRH-reseptorsignalering, mens Ipamorelin driver selektive ghrelinreseptorpulser. Forskning tyder på synergistiske, naturalistiske GH-frigjøringsmønstre hos studiedeltakere.

Labrapport

HPLC-verifisert mot en renhetsspesifikasjon på ≥99 %. Uavhengig testet av akkrediterte tredjepartslaboratorier.

CJC-1295: DAC vs no-DAC

CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.

FAQ for forskere

CJC-1295 + Ipamorelin — vanlige spørsmål

What is the CJC-1295 + Ipamorelin stack?

It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.

How does CJC-1295 differ from Ipamorelin?

CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.

Is CJC-1295 + Ipamorelin legal in Australia?

Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.

What does selective mean for Ipamorelin?

Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.

What is the typical CJC-1295 + Ipamorelin research dosage?

Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.

Are CJC-1295 and Ipamorelin used together?

Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.

Videre lesing

Guider relatert til CJC-1295 + Ipamorelin

Relaterte forbindelser

Forskere utforsker også

HGHUtvalgtPakke med 10 hetteglassSpar 17 %

HGH

Lyofilisert pulver

10 IU · 4 strengths

Rekombinant humant veksthormon

I 2 stacker
1 182 kr NOK
Spar 17 %
Pakke med 10 hetteglass
Før 1 422 kr NOK
Se detaljer →
TesamorelinPakke med 10 hetteglassSpar 18 %

Tesamorelin

Lyofilisert pulver

10 mg · 3 strengths

Stabilisert GHRH-analog

I 1 stack
3 802 kr NOK
Spar 18 %
Pakke med 10 hetteglass
Før 4 636 kr NOK
Se detaljer →
Melanotan IIUtvalgtPakke med 10 hetteglassSpar 22 %

Melanotan II

Lyofilisert pulver

10 mg

α-MSH-analog forskningspeptid

1 202 kr NOK
Spar 22 %
Pakke med 10 hetteglass
Før 1 540 kr NOK
Se detaljer →